1. Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study. Issue 6 (November 2014) Authors: Iwahashi, Mitsuhiro; Inoue, Hiroshi; Matsubara, Tsukasa; Tanaka, Takaaki; Amano, Koichi; Kanamono, Toshihisa; Nakano, Teruaki; Uchimura, Shoichi; Izumihara, Tomomaro; Yamazaki, Akira; Karyekar, Chetan S.; Takeuchi, Tsutomu Journal: Modern rheumatology Issue: Volume 24:Issue 6(2014) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders. Issue 5 (September 2015) Authors: Amano, Koichi; Matsubara, Tsukasa; Tanaka, Takaaki; Inoue, Hiroshi; Iwahashi, Mitsuhiro; Kanamono, Toshihisa; Nakano, Teruaki; Uchimura, Shoichi; Izumihara, Tomomaro; Yamazaki, Akira; Karyekar, Chetan S.; Takeuchi, Tsutomu; Japan Abatacept Study Group Journal: Modern rheumatology Issue: Volume 25:Issue 5(2015) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗